UNRESECTABLE LOCALLY ADVANCED PANCREATIC CARCINOMA

Clinical trials for UNRESECTABLE LOCALLY ADVANCED PANCREATIC CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE LOCALLY ADVANCED PANCREATIC CARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE LOCALLY ADVANCED PANCREATIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for hard-to-treat pancreatic cancer?

Disease control Not yet recruiting

This early-phase trial tests whether adding an experimental drug called NRT6008 to standard chemotherapy is safe and effective for people with locally advanced pancreatic cancer that cannot be removed by surgery. About 10 adults aged 18 to 85 will take part. The main goal is to c…

Matched conditions: UNRESECTABLE LOCALLY ADVANCED PANCREATIC CARCINOMA

Phase: PHASE1 • Sponsor: NRT MedTech Australia Pty Ltd • Aim: Disease control

Last updated May 12, 2026 13:40 UTC

UNRESECTABLE LOCALLY ADVANCED PANCREATIC CARCINOMA

Get alerted when new UNRESECTABLE LOCALLY ADVANCED PANCREATIC CARCINOMA trials appear

New hope for hard-to-treat pancreatic cancer?